Skip to main content
Log in

SENESCENCE

NAD+: a metabolic knob fine-tuning inflammation during senescence

  • News & Views
  • Published:

From Nature Metabolism

View current issue Submit your manuscript

The senescence-associated secretory phenotype (SASP) is responsible for the deleterious effects of senescent cells in ageing and cancer. A new study shows that NAD+ metabolism can regulate the pro-inflammatory SASP, thereby promoting tumorigenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: NAD+ metabolism regulates the pro-inflammatory SASP and can promote tumour progression.

References

  1. Herranz, N. & Gil, J. J. Clin. Invest. 128, 1238–1246 (2018).

    Article  Google Scholar 

  2. Georgilis, A. et al. Cancer Cell 34, 85–102.e109 (2018).

    Article  CAS  Google Scholar 

  3. Nacarelli, T. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-019-0287-4 (2019).

  4. Narita, M. et al. Cell 126, 503–514 (2006).

    Article  CAS  Google Scholar 

  5. Garten, A. et al. Nat. Rev. Endocrinol. 11, 535–546 (2015).

    Article  CAS  Google Scholar 

  6. Rielland, M. et al. J. Clin. Invest. 124, 2125–2135 (2014).

    Article  CAS  Google Scholar 

  7. Kaplon, J. et al. Nature 498, 109–112 (2013).

    Article  CAS  Google Scholar 

  8. Rajman, L., Chwalek, K. & Sinclair, D. A. Cell Metab. 27, 529–547 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jesús Gil.

Ethics declarations

Competing interests

J.G. owns equity in and is a consultant for Unity Biotechnology. Unity Biotechnology funds research on senolytics in the laboratory of J.G. J.G is a named inventor in a filed MRC patent related to senolytic therapies (PCT/GB2018/051437) that has been licensed to Unity Biotechnology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Søgaard, P.P., Gil, J. NAD+: a metabolic knob fine-tuning inflammation during senescence. Nat Metab 1, 310–311 (2019). https://doi.org/10.1038/s42255-019-0047-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-019-0047-6

  • Springer Nature Limited

Navigation